CN103804509A - Preparation method of selenylation algal polysaccharides with high biological activity - Google Patents
Preparation method of selenylation algal polysaccharides with high biological activity Download PDFInfo
- Publication number
- CN103804509A CN103804509A CN201410101634.6A CN201410101634A CN103804509A CN 103804509 A CN103804509 A CN 103804509A CN 201410101634 A CN201410101634 A CN 201410101634A CN 103804509 A CN103804509 A CN 103804509A
- Authority
- CN
- China
- Prior art keywords
- sargassum polysaccharides
- selenizing
- polysaccharides
- biological activity
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920001282 polysaccharide Polymers 0.000 title claims abstract description 102
- 239000005017 polysaccharide Substances 0.000 title claims abstract description 102
- 150000004676 glycans Chemical class 0.000 title claims abstract description 100
- 230000004071 biological effect Effects 0.000 title claims abstract description 16
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 25
- 239000000243 solution Substances 0.000 claims abstract description 25
- 238000003756 stirring Methods 0.000 claims abstract description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 14
- 238000006243 chemical reaction Methods 0.000 claims abstract description 11
- WDIHJSXYQDMJHN-UHFFFAOYSA-L barium chloride Chemical compound [Cl-].[Cl-].[Ba+2] WDIHJSXYQDMJHN-UHFFFAOYSA-L 0.000 claims abstract description 10
- 229910001626 barium chloride Inorganic materials 0.000 claims abstract description 10
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims abstract description 9
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 claims abstract description 8
- 229960001471 sodium selenite Drugs 0.000 claims abstract description 8
- 235000015921 sodium selenite Nutrition 0.000 claims abstract description 8
- 239000011781 sodium selenite Substances 0.000 claims abstract description 8
- 241001428166 Eucheuma Species 0.000 claims abstract description 7
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 claims abstract description 6
- 239000007864 aqueous solution Substances 0.000 claims abstract description 6
- 229910017604 nitric acid Inorganic materials 0.000 claims abstract description 6
- 241000195474 Sargassum Species 0.000 claims description 69
- 238000001556 precipitation Methods 0.000 claims description 20
- 238000000605 extraction Methods 0.000 claims description 13
- 238000001035 drying Methods 0.000 claims description 12
- 238000000967 suction filtration Methods 0.000 claims description 12
- 229940045511 barium chloride Drugs 0.000 claims description 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 8
- 229960000935 dehydrated alcohol Drugs 0.000 claims description 8
- 238000005406 washing Methods 0.000 claims description 8
- 229960004756 ethanol Drugs 0.000 claims description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 4
- 229920004934 Dacron® Polymers 0.000 claims description 4
- 238000009835 boiling Methods 0.000 claims description 4
- 239000012295 chemical reaction liquid Substances 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 4
- 238000000502 dialysis Methods 0.000 claims description 4
- 238000004821 distillation Methods 0.000 claims description 4
- 239000012153 distilled water Substances 0.000 claims description 4
- 239000004744 fabric Substances 0.000 claims description 4
- 239000000706 filtrate Substances 0.000 claims description 4
- 239000005020 polyethylene terephthalate Substances 0.000 claims description 4
- 229910052938 sodium sulfate Inorganic materials 0.000 claims description 4
- 235000011152 sodium sulphate Nutrition 0.000 claims description 4
- 229910052711 selenium Inorganic materials 0.000 abstract description 23
- 239000011669 selenium Substances 0.000 abstract description 23
- 229940091258 selenium supplement Drugs 0.000 abstract description 23
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 abstract description 21
- 238000001914 filtration Methods 0.000 abstract description 4
- 230000035790 physiological processes and functions Effects 0.000 abstract description 4
- 239000011573 trace mineral Substances 0.000 abstract description 3
- 235000013619 trace mineral Nutrition 0.000 abstract description 3
- 230000036541 health Effects 0.000 abstract description 2
- 238000000034 method Methods 0.000 abstract description 2
- 239000000203 mixture Substances 0.000 abstract description 2
- 235000016709 nutrition Nutrition 0.000 abstract description 2
- 230000035764 nutrition Effects 0.000 abstract description 2
- 239000002244 precipitate Substances 0.000 abstract 3
- 238000001704 evaporation Methods 0.000 abstract 1
- 230000008020 evaporation Effects 0.000 abstract 1
- 238000010438 heat treatment Methods 0.000 abstract 1
- 230000001376 precipitating effect Effects 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 36
- 230000000452 restraining effect Effects 0.000 description 13
- 230000002401 inhibitory effect Effects 0.000 description 12
- 229920001525 carrageenan Polymers 0.000 description 11
- 235000010418 carrageenan Nutrition 0.000 description 11
- 230000000694 effects Effects 0.000 description 7
- 206010028980 Neoplasm Diseases 0.000 description 6
- 230000000259 anti-tumor effect Effects 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- -1 selenium polysaccharide Chemical class 0.000 description 6
- 241000700605 Viruses Species 0.000 description 5
- 150000003254 radicals Chemical class 0.000 description 5
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 4
- 241000206572 Rhodophyta Species 0.000 description 4
- 230000000840 anti-viral effect Effects 0.000 description 4
- 230000004663 cell proliferation Effects 0.000 description 4
- 201000005296 lung carcinoma Diseases 0.000 description 4
- 201000009030 Carcinoma Diseases 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 210000000867 larynx Anatomy 0.000 description 3
- 208000032839 leukemia Diseases 0.000 description 3
- 230000033001 locomotion Effects 0.000 description 3
- 230000000630 rising effect Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 208000005623 Carcinogenesis Diseases 0.000 description 2
- 229920001491 Lentinan Polymers 0.000 description 2
- 210000001744 T-lymphocyte Anatomy 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000010100 anticoagulation Effects 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000036952 cancer formation Effects 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 231100000504 carcinogenesis Toxicity 0.000 description 2
- 230000003013 cytotoxicity Effects 0.000 description 2
- 231100000135 cytotoxicity Toxicity 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 150000002148 esters Chemical group 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000002147 killing effect Effects 0.000 description 2
- 229940115286 lentinan Drugs 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 210000000822 natural killer cell Anatomy 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 229940082569 selenite Drugs 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- 241001430294 unidentified retrovirus Species 0.000 description 2
- IBZYPBGPOGJMBF-UHFFFAOYSA-N 3,6 anhydrogalactose Natural products CCC=CCC1C(CC(=O)NC(C(C)CC)C(O)=O)CCC1=O IBZYPBGPOGJMBF-UHFFFAOYSA-N 0.000 description 1
- WZYRMLAWNVOIEX-BGPJRJDNSA-N 3,6-anhydro-D-galactose Chemical compound O=C[C@H](O)[C@H]1OC[C@@H](O)[C@@H]1O WZYRMLAWNVOIEX-BGPJRJDNSA-N 0.000 description 1
- PMYDPQQPEAYXKD-UHFFFAOYSA-N 3-hydroxy-n-naphthalen-2-ylnaphthalene-2-carboxamide Chemical compound C1=CC=CC2=CC(NC(=O)C3=CC4=CC=CC=C4C=C3O)=CC=C21 PMYDPQQPEAYXKD-UHFFFAOYSA-N 0.000 description 1
- DCQFFOLNJVGHLW-UHFFFAOYSA-N 4'-Me ether-Punctatin+ Natural products O1C(O)C(O)C2OCC1C2O DCQFFOLNJVGHLW-UHFFFAOYSA-N 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 230000004543 DNA replication Effects 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010019799 Hepatitis viral Diseases 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- 102000012750 Membrane Glycoproteins Human genes 0.000 description 1
- 108010090054 Membrane Glycoproteins Proteins 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 108700020796 Oncogene Proteins 0.000 description 1
- 208000037273 Pathologic Processes Diseases 0.000 description 1
- 102000003923 Protein Kinase C Human genes 0.000 description 1
- 108090000315 Protein Kinase C Proteins 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 102000008114 Selenoproteins Human genes 0.000 description 1
- 108010074686 Selenoproteins Proteins 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 102100040247 Tumor necrosis factor Human genes 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical group OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002019 anti-mutation Effects 0.000 description 1
- 230000010056 antibody-dependent cellular cytotoxicity Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000003699 antiulcer agent Substances 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000005859 cell recognition Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- WZYRMLAWNVOIEX-UHFFFAOYSA-N cinnamtannin B-2 Natural products O=CC(O)C1OCC(O)C1O WZYRMLAWNVOIEX-UHFFFAOYSA-N 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000008175 fetal development Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 230000002008 hemorrhagic effect Effects 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000000527 lymphocytic effect Effects 0.000 description 1
- 210000003810 lymphokine-activated killer cell Anatomy 0.000 description 1
- 239000008291 lyophilic colloid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000009054 pathological process Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920000447 polyanionic polymer Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 230000001603 reducing effect Effects 0.000 description 1
- 230000009711 regulatory function Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 229960001881 sodium selenate Drugs 0.000 description 1
- 235000018716 sodium selenate Nutrition 0.000 description 1
- 239000011655 sodium selenate Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 229910052718 tin Inorganic materials 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 201000001862 viral hepatitis Diseases 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Images
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410101634.6A CN103804509B (en) | 2014-03-19 | 2014-03-19 | A kind of selenizing algal polysaccharides preparation method of high bioactivity |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410101634.6A CN103804509B (en) | 2014-03-19 | 2014-03-19 | A kind of selenizing algal polysaccharides preparation method of high bioactivity |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103804509A true CN103804509A (en) | 2014-05-21 |
CN103804509B CN103804509B (en) | 2016-05-25 |
Family
ID=50701937
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410101634.6A Active CN103804509B (en) | 2014-03-19 | 2014-03-19 | A kind of selenizing algal polysaccharides preparation method of high bioactivity |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103804509B (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104604930A (en) * | 2015-02-04 | 2015-05-13 | 青岛鹏洋生物工程有限公司 | Preparation method of plant selenium enrichment enhancer |
CN106074868A (en) * | 2016-07-15 | 2016-11-09 | 浙江省海洋开发研究院 | A kind of selenizing polysaccharide immunostimulant |
CN107400172A (en) * | 2017-07-20 | 2017-11-28 | 房俊英 | A kind of bioactive substance extracting method |
CN107549123A (en) * | 2017-10-18 | 2018-01-09 | 湖北聚注通用技术研究有限公司 | A kind of scorpion breeding method |
CN110272504A (en) * | 2019-06-18 | 2019-09-24 | 广东医科大学 | The preparation method and selenizing flat algae exocellular polysaccharide of selenizing flat algae exocellular polysaccharide |
CN110742964A (en) * | 2019-11-06 | 2020-02-04 | 国泰振兴科技发展有限公司 | Medicine composition for treating lung cancer and preparation method thereof |
CN111978420A (en) * | 2020-08-19 | 2020-11-24 | 青岛谦和信科技服务有限公司 | Preparation method of spirulina selenium polysaccharide |
CN115736112A (en) * | 2022-11-15 | 2023-03-07 | 西北农林科技大学 | Feed additive for reducing diarrhea rate of lactating calves and preparation method thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1288899A (en) * | 2000-08-04 | 2001-03-28 | 国家***第一海洋研究所 | Selenium compound of polysaccharide and its preparation |
CN101104646A (en) * | 2007-05-31 | 2008-01-16 | 暨南大学 | Preparation method for eucheuma gelatinae polysaccharide selenide and application |
-
2014
- 2014-03-19 CN CN201410101634.6A patent/CN103804509B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1288899A (en) * | 2000-08-04 | 2001-03-28 | 国家***第一海洋研究所 | Selenium compound of polysaccharide and its preparation |
CN101104646A (en) * | 2007-05-31 | 2008-01-16 | 暨南大学 | Preparation method for eucheuma gelatinae polysaccharide selenide and application |
Non-Patent Citations (1)
Title |
---|
赵玉苹: "海藻硒多糖的合成及生物活性研究", 《中国优秀硕士学位论文全文数据库医药卫生科技辑》 * |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104604930A (en) * | 2015-02-04 | 2015-05-13 | 青岛鹏洋生物工程有限公司 | Preparation method of plant selenium enrichment enhancer |
CN106074868A (en) * | 2016-07-15 | 2016-11-09 | 浙江省海洋开发研究院 | A kind of selenizing polysaccharide immunostimulant |
CN107400172A (en) * | 2017-07-20 | 2017-11-28 | 房俊英 | A kind of bioactive substance extracting method |
CN107549123A (en) * | 2017-10-18 | 2018-01-09 | 湖北聚注通用技术研究有限公司 | A kind of scorpion breeding method |
CN110272504A (en) * | 2019-06-18 | 2019-09-24 | 广东医科大学 | The preparation method and selenizing flat algae exocellular polysaccharide of selenizing flat algae exocellular polysaccharide |
CN110742964A (en) * | 2019-11-06 | 2020-02-04 | 国泰振兴科技发展有限公司 | Medicine composition for treating lung cancer and preparation method thereof |
CN111978420A (en) * | 2020-08-19 | 2020-11-24 | 青岛谦和信科技服务有限公司 | Preparation method of spirulina selenium polysaccharide |
CN115736112A (en) * | 2022-11-15 | 2023-03-07 | 西北农林科技大学 | Feed additive for reducing diarrhea rate of lactating calves and preparation method thereof |
CN115736112B (en) * | 2022-11-15 | 2024-05-14 | 西北农林科技大学 | Feed additive for reducing diarrhea rate of lactating calves and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN103804509B (en) | 2016-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103804509B (en) | A kind of selenizing algal polysaccharides preparation method of high bioactivity | |
CN104277134B (en) | A kind of preparation method and applications of the dictyophora fungus polysaccharide-chelates of zinc with anti-tumor activity | |
CN106265754A (en) | A kind of method that a chain of extraction obtains two kinds of effective ingredient from periplaneta americana | |
CN105153319B (en) | A kind of application of sealwort paragalactan and preparation method thereof and anti-inflammatory aspect | |
CN101104643A (en) | Polysaccharide sulfate selenide compound and its preparation method and application | |
CN102532339A (en) | Method for selenizing pilose asiabell root polysaccharides and application of product | |
CN103880910A (en) | Preparation method and application of cycloastragenol | |
CN102552644A (en) | Anti-tumor use, preparation method and composition of garlic total polysaccharide | |
CN103435715A (en) | Preparation method and application of vanadium complexes of oligosaccharides and derivatives thereof | |
CN106084087A (en) | A kind of preparation method of Fructus Trichosanthis polysaccharide | |
CN104042623A (en) | Application of rhizopus nigricans exopolysaccharides in preparation of medicine for treating or preventing gastrointestinal tumors | |
CN105769926A (en) | Skin mucus extracts of andrias davidianus Blanchard for preparing anti-breast cancer drugs and application thereof | |
CN110041441B (en) | Safflower polysaccharide, preparation method thereof and application thereof in antitumor drugs | |
CN105796587B (en) | Caulis bambusae in taenian polysaccharide immunological regulation, it is antitumor in application | |
CN102653566A (en) | Method for preparing astragalus polysaccharide selenide by using organic method | |
CN103356736A (en) | Dyetree fruit polyphenol extract with antineoplastic effect and preparation method thereof | |
CN102225198B (en) | Anti-tumour medicine composition and preparation method and application thereof | |
CN108864316B (en) | Sulfonated peony seed polysaccharide and application thereof in preparation of auxiliary medicine for treating liver cancer | |
CN100562526C (en) | Oligomeric glucose sulfuric ester and preparation method thereof | |
CN111643517A (en) | Application of mulberry polysaccharide derivative S-MFP-30 in preparation of antitumor drugs | |
CN104523792B (en) | A kind of milkweed latex extract rich in cardiac glycoside and preparation method and application | |
CN103275237A (en) | Preparation method and application of eggplant branch polysaccharide | |
CN113717296B (en) | Eucommia acidic polysaccharide, extraction method and application of eucommia acidic polysaccharide in preparation of anti-colon cancer drugs | |
CN102633899B (en) | Selenized microbial exopolysaccharide, and preparation method and uses thereof | |
CN102805829B (en) | Preparation method of rhizoma smilacis glabrae extract and applications thereof in tumor treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: ZHANGZHOU XINMING BIO-TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: XU ZILIN Effective date: 20150515 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20150515 Address after: 362700 Fujian city of Quanzhou province Shishi Han Jiang Zhen CuO Zi Jian Ming Industrial Zone No. 35 Applicant after: Zhangzhou Xinming Biological Technology Co. Ltd. Address before: 362700 Fujian city of Quanzhou province Shishi Haojiang Lijing Building 1 E 1001 ladder Applicant before: Xu Zilin |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160214 Address after: 362700 Fujian city of Quanzhou province Shishi Han Jiang Zhen CuO Zi Jian Ming Industrial Zone No. 35 Applicant after: Shishi Xinming Food Science and Technology Development Co.,Ltd. Address before: 362700 Fujian city of Quanzhou province Shishi Han Jiang Zhen CuO Zi Jian Ming Industrial Zone No. 35 Applicant before: Zhangzhou Xinming Biological Technology Co. Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180211 Address after: No. 12, Shi Jing expressway, Nanjing high tech Industrial Park, Zhangzhou, Fujian Patentee after: Zhangzhou Xinming Biological Technology Co. Ltd. Address before: 362700 Fujian city of Quanzhou province Shishi Han Jiang Zhen CuO Zi Jian Ming Industrial Zone No. 35 Patentee before: Shishi Xinming Food Science and Technology Development Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
CP02 | Change in the address of a patent holder |
Address after: 363600 Nanjing hi tech Industrial Park, Fujian, Zhangzhou Patentee after: ZHANGZHOU XINMING BIOTECHNOLOGY Co.,Ltd. Address before: No. 12, Shi Jing expressway, Nanjing high tech Industrial Park, Zhangzhou, Fujian Patentee before: ZHANGZHOU XINMING BIOTECHNOLOGY Co.,Ltd. |
|
CP02 | Change in the address of a patent holder |